Drug Safety Information for ESTRADIOL AND NORETHINDRONE ACETATE (Estradiol; norethindrone acetate)

Safety-related Labeling Changes for COMBIPATCH (ESTRADIOL; NORETHINDRONE ACETATE) Rx Drug: FDA Link

Safety-related Labeling Changes for ACTIVELLA (ESTRADIOL; NORETHINDRONE ACETATE) Rx Drug: FDA Link

Adverse Drug Reactions for ESTRADIOL AND NORETHINDRONE ACETATE* (Estradiol; norethindrone acetate)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with ESTRADIOL AND NORETHINDRONE ACETATE
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Breast cancer418
2Breast cancer female275
3Nausea78
4Pain74
5Depression71
6Anxiety64
7Headache64
8Fatigue62
9Breast cancer metastatic60
10Drug ineffective58
11Hot flush58
12Dizziness50
13Insomnia46
14Pain in extremity41
15Diarrhoea38
16Product quality issue38
17Oestrogen receptor assay positive37
18Arthralgia35
19Asthenia33
20Breast cancer in situ33

* This side effect also appears in "Top 10 Side Effects of ESTRADIOL AND NORETHINDRONE ACETATE " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking ESTRADIOL AND NORETHINDRONE ACETATE
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Hormone replacement therapy1274
2Menopause*934
3Menopausal symptoms*468
4Product used for unknown indication335
5Hot flush*167
6Hormone therapy49
7Hormone level abnormal32
8Postmenopause27
9Menstrual cycle management22
10Menorrhagia20

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for ESTRADIOL AND NORETHINDRONE ACETATE

Total Reports Filed with FDA: 6457


Number of FDA Adverse Event Reports by Patient Age for ESTRADIOL AND NORETHINDRONE ACETATE

Total Reports Filed with FDA: 6457*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Estradiol; norethindrone acetate (Mimvey, Mimvey lo, Combipatch, Activella)

Charts are based on 6457 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and ESTRADIOL AND NORETHINDRONE ACETATE Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.